75 岁以上老年抗栓治疗专家共识

2017-06-20 海峡两岸医药卫生交流协会老年医学专业委员会 中国循环杂志.2017,32(6):531-538.

75 岁以上(≥ 75 岁)老年人是心血管疾病的高发人群,且随着年龄增长,发病率呈显著增加趋势。约1/3 罹患心肌梗死和2/3 因心肌梗死死亡的患者超过75 岁。制订《75 岁以上老年抗栓治疗专家共识》,旨在通过总结临床研究结果并引入新的出血风险评分系统,提出适合我国75 岁以上高龄患者的评价体系和抗栓建议。

中文标题:

75 岁以上老年抗栓治疗专家共识

发布日期:

2017-06-20

简要介绍:

75 岁以上(≥ 75 岁)老年人是心血管疾病的高发人群,且随着年龄增长,发病率呈显著增加趋势。约1/3 罹患心肌梗死和2/3 因心肌梗死死亡的患者超过75 岁。制订《75 岁以上老年抗栓治疗专家共识》,旨在通过总结临床研究结果并引入新的出血风险评分系统,提出适合我国75 岁以上高龄患者的评价体系和抗栓建议。

 

拓展指南:抗栓治疗相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=75 岁以上老年抗栓治疗专家共识)] GetToolGuiderByIdResponse(projectId=1, id=a3a531c001a914f3, title=75 岁以上老年抗栓治疗专家共识, enTitle=, guiderFrom=中国循环杂志.2017,32(6):531-538., authorId=null, author=, summary=75 岁以上(≥ 75 岁)老年人是心血管疾病的高发人群,且随着年龄增长,发病率呈显著增加趋势。约1/3 罹患心肌梗死和2/3 因心肌梗死死亡的患者超过75 岁。制订《75 岁以上老年抗栓治疗专家共识》,旨在通过总结临床研究结果并引入新的出血风险评分系统,提出适合我国75 岁以上高龄患者的评价体系和抗栓建议。 , cover=, journalId=null, articlesId=null, associationId=1517, associationName=海峡两岸医药卫生交流协会老年医学专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Tue Jun 20 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>75 岁以上(≥ 75 岁)老年人是心血管疾病的高发人群,且随着年龄增长,发病率呈显著增加趋势。约1/3 罹患心肌梗死和2/3 因心肌梗死死亡的患者超过75 岁。制订《75 岁以上老年抗栓治疗专家共识》,旨在通过总结临床研究结果并引入新的出血风险评分系统,提出适合我国75 岁以上高龄患者的评价体系和抗栓建议。 </P> <P> </P>拓展指南:<STRONG>与<FONT color=red>抗栓治疗</FONT>相关指南:</STRONG><BR> <UL> <LI><A title="静脉血栓栓塞疾病的抗栓治疗 —第10 版美国胸科医师学会抗栓治疗指南解读" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=141681c001a0600f">静脉血栓栓塞疾病的抗栓治疗 —第10 版美国胸科医师学会抗栓治疗指南解读</A> <LI><A title="2016 SFORL指南:抗栓治疗导致的鼻出血凝血障碍的管理" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=7b8ae1c00132808f">2016 SFORL指南:抗栓治疗导致的鼻出血凝血障碍的管理</A> <LI><A title="2016 ESC专家共识:冠状动脉疾病和/或房颤患者出血后抗栓治疗管理" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=d36f81c0013223da">2016 ESC专家共识:冠状动脉疾病和/或房颤患者出血后抗栓治疗管理</A> <LI><A title="2016 急性冠状动脉综合征抗栓治疗合并出血防治多学科专家共识" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=f54b51c001321af7">2016 急性冠状动脉综合征抗栓治疗合并出血防治多学科专家共识</A> <LI><A title="2016 抗栓治疗消化道损伤防治中国专家建议(2016·北京)" target=_blank href="http://www.medsci.cn/guideline/show_article.do?id=d9ff71c0012a635e">2016 抗栓治疗消化道损伤防治中国专家建议(2016·北京)</A> 更多信息请点击:<A target=_blank href="http://www.medsci.cn/guideline/list.do?q=%E6%8A%97%E6%A0%93%E6%B2%BB%E7%96%97">有关抗栓治疗更多指南</A></LI></UL>, tagList=[TagDto(tagId=2575, tagName=老年人), TagDto(tagId=3301, tagName=抗栓治疗)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5732, appHits=318, showAppHits=0, pcHits=4164, showPcHits=2216, likes=146, shares=15, comments=5, approvalStatus=1, publishedTime=Mon Sep 04 22:41:13 CST 2017, publishedTimeString=2017-06-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Sep 04 22:41:13 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 03:05:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=75 岁以上老年抗栓治疗专家共识)])
75 岁以上老年抗栓治疗专家共识
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=244435, encodeId=27f2244435b8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Sep 16 00:03:53 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244227, encodeId=f9a524422ed2, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95522146690, createdName=13920009cbm, createdTime=Fri Sep 15 08:15:08 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242483, encodeId=ad6d24248306, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32c62144652, createdName=1391ff9fb5m, createdTime=Sun Sep 10 09:40:02 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240852, encodeId=0f082408522b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Sep 05 23:27:55 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240699, encodeId=16f3240699c0, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Sep 05 10:49:35 CST 2017, time=2017-09-05, status=1, ipAttribution=)]
    2017-09-16 yfjms

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=244435, encodeId=27f2244435b8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Sep 16 00:03:53 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244227, encodeId=f9a524422ed2, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95522146690, createdName=13920009cbm, createdTime=Fri Sep 15 08:15:08 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242483, encodeId=ad6d24248306, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32c62144652, createdName=1391ff9fb5m, createdTime=Sun Sep 10 09:40:02 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240852, encodeId=0f082408522b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Sep 05 23:27:55 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240699, encodeId=16f3240699c0, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Sep 05 10:49:35 CST 2017, time=2017-09-05, status=1, ipAttribution=)]
    2017-09-15 13920009cbm

    不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=244435, encodeId=27f2244435b8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Sep 16 00:03:53 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244227, encodeId=f9a524422ed2, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95522146690, createdName=13920009cbm, createdTime=Fri Sep 15 08:15:08 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242483, encodeId=ad6d24248306, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32c62144652, createdName=1391ff9fb5m, createdTime=Sun Sep 10 09:40:02 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240852, encodeId=0f082408522b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Sep 05 23:27:55 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240699, encodeId=16f3240699c0, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Sep 05 10:49:35 CST 2017, time=2017-09-05, status=1, ipAttribution=)]
    2017-09-10 1391ff9fb5m

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=244435, encodeId=27f2244435b8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Sep 16 00:03:53 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244227, encodeId=f9a524422ed2, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95522146690, createdName=13920009cbm, createdTime=Fri Sep 15 08:15:08 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242483, encodeId=ad6d24248306, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32c62144652, createdName=1391ff9fb5m, createdTime=Sun Sep 10 09:40:02 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240852, encodeId=0f082408522b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Sep 05 23:27:55 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240699, encodeId=16f3240699c0, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Sep 05 10:49:35 CST 2017, time=2017-09-05, status=1, ipAttribution=)]
    2017-09-05 有备才能无患

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=244435, encodeId=27f2244435b8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Sep 16 00:03:53 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=244227, encodeId=f9a524422ed2, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95522146690, createdName=13920009cbm, createdTime=Fri Sep 15 08:15:08 CST 2017, time=2017-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242483, encodeId=ad6d24248306, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32c62144652, createdName=1391ff9fb5m, createdTime=Sun Sep 10 09:40:02 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240852, encodeId=0f082408522b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Tue Sep 05 23:27:55 CST 2017, time=2017-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=240699, encodeId=16f3240699c0, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Sep 05 10:49:35 CST 2017, time=2017-09-05, status=1, ipAttribution=)]
    2017-09-05 Y—xianghai

    学习了新知识

    0